Two important improvements over earlier reports are (i) our SW620 observations relate to a human carcinoma line, enabling insights to the EGF pathway in cancer directly and (ii) we have spatial information concerning EGFR and EGF localization simultaneously from labelled protein and ligand. The gene discussed is EGFR; the disease is cancer.